Guided Therapeutics (GTHP) Stock Analysis & Winston Score

Winston Score History

Guided Therapeutics is a small medical device company that makes a tool to help doctors detect cervical cancer earlier. Its main product is the LuViva Advanced Cervical Scan, a non-invasive device that uses light to check cervical tissue without needing a biopsy or lab test. The company sells to healthcare providers and targets markets where cervical cancer screening is limited or underserved.

The company earns revenue by selling its scanning devices and related disposable components used during each exam. It operates primarily in international markets, including parts of Asia and the Middle East, where regulatory approvals have been easier to obtain than in the United States. Guided Therapeutics is a very small company with a market cap near zero, and its deep operating losses show it spends far more than it earns. The biggest risk is whether it can secure enough funding and regulatory clearances to scale sales before running out of cash.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+42.2% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

58.5%ownership

↓ Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~0 months

$12,000 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

Guided Therapeutics has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

Data not available

Profit after running costs

Operating Margin

N/A

Data not available

Return on the money invested

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+450.8%

Fast-growing sales (+450.8% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-231.7%

Burning cash (-231.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial